glp-1 news nov 2025 Pipeline Update: August - Prime Therapeutics Eli Lilly to seek approval
Description
Weight suppression is a significant risk factor in eating disorder development and recovery outcomes
Did someone do something wrong

Nakatani Y, Kawabe A, Matsumura M, et al
Pharmacol Biochem Behav 1997;58:76773

This phenomenon isnt unique to GLP-1

M.KleefstraT.YntemaH
